These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 334070)

  • 41. Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance.
    Chen J; Lee EW; Kuroda T; Mizushima T; Tsuchiya T
    Biol Pharm Bull; 2003 Mar; 26(3):391-3. PubMed ID: 12612456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transductional construction of a threonine-hyperproducing strain of Serratia marcescens: lack of feedback controls of three aspartokinases and two homoserine dehydrogenases.
    Komatsubara S; Kisumi M; Chibata I
    Appl Environ Microbiol; 1983 May; 45(5):1445-52. PubMed ID: 6307143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
    Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular nature and replication of drug resistance factors of the Enterobacteriaceae.
    Rownd R; Kasamatsu H; Mickel S
    Ann N Y Acad Sci; 1971 Jun; 182():188-206. PubMed ID: 4936662
    [No Abstract]   [Full Text] [Related]  

  • 45. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A relationship between R plasmids and increased incidence of nonpigmenting drug-resistant Serratia marcescens from clinical sources].
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Nihon Saikingaku Zasshi; 1982 Nov; 37(6):931-7. PubMed ID: 6763638
    [No Abstract]   [Full Text] [Related]  

  • 47. Construction of a urocanic acid-producing strain of Serratia marcescens by transduction.
    Kisumi M; Nakanishi N; Takagi T; Chibata I
    Appl Environ Microbiol; 1978 Feb; 35(2):231-6. PubMed ID: 345965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-directed mutagenesis studies to probe the role of specific residues in the external loop (L3) of OmpF and OmpC porins in susceptibility of Serratia marcescens to antibiotics.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Jun; 53(6):710-9. PubMed ID: 17668031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methionine-repressible homoserine dehydrogenase of Serratia marcescens: purification and properties.
    Shailaja MS; Raghavendra Rao MR
    Mol Cell Biochem; 1976 Jul; 12(1):15-22. PubMed ID: 184374
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Instability of an arginine-overproducing mutant of Serratia marcescens and its stabilization.
    Takagi T; Sugiura M; Kisumi M
    J Biochem; 1986 Feb; 99(2):357-64. PubMed ID: 3516981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quinolone resistance in clinical isolates of Serratia marcescens.
    Fujimaki K; Fujii T; Aoyama H; Sato K; Inoue Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 May; 33(5):785-7. PubMed ID: 2546493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolation and characterization of norleucine-resistant baby hamster kidney cells.
    Kamely D; Littlefield JW
    Exp Cell Res; 1974 Nov; 89(1):154-60. PubMed ID: 4373259
    [No Abstract]   [Full Text] [Related]  

  • 54. Derepression of isoleucine-valine biosynthetic enzymes and extracellular isoleucine accumulation in Serratia marcescens.
    Kisumi M; Komatsubara S; Chibata I
    J Biochem; 1972 Nov; 72(5):1065-73. PubMed ID: 4567661
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of the Serratia marcescens SdeCDE multidrug efflux pump studied via gene knockout mutagenesis.
    Begic S; Worobec EA
    Can J Microbiol; 2008 May; 54(5):411-6. PubMed ID: 18449226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norvaline and norleucine may have been more abundant protein components during early stages of cell evolution.
    Alvarez-Carreño C; Becerra A; Lazcano A
    Orig Life Evol Biosph; 2013 Oct; 43(4-5):363-75. PubMed ID: 24013929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the outer membrane in the accumulation of quinolones by Serratia marcescens.
    Berlanga M; Ruiz N; Hernandez-Borrell J; Montero T; Viñas M
    Can J Microbiol; 2000 Aug; 46(8):716-22. PubMed ID: 10941517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of exogenous amino acids on the multiplication of porcine Escherichia coli.
    Aning KG; Thomlinson JR
    Vet Microbiol; 1989 Mar; 19(3):263-73. PubMed ID: 2497578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical characteristics and antibiotic susceptibilities of Serratia marcescens isolated from clinical specimens.
    Chong Y; Yi KN; Lee SY
    Yonsei Med J; 1978; 19(1):32-8. PubMed ID: 382648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.